Hybrid Renal Cell Carcinomas Containing Histopathologic Features of Chromophobe Renal Cell Carcinomas and Oncocytomas Have Excellent Oncologic Outcomes

European Urology

Volumn 57, Issue 4, 2010, Pages 661-666

  Waldert, Matthias ^a   Klatte, Tobias ^a   Haitel, Andrea ^a   Ozsoy, Mehmet ^a   Schmidbauer, Joerg ^a   Marberger, Michael ^a   Remzi, Mesut ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chromophobe renal cell carcinoma; Hybrid renal cell carcinoma; Oncocytoma; Renal tumor biopsy

Indexed keywords

CYTOKERATIN 7;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; ONCOCYTOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL;

ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; BIOPSY; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATIN-7; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, COMPLEX AND MIXED; NEPHRECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77249085625     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.05.009     Document Type: Article

References (24)

1. Beisland C., Hjelle K.M., Reisæter L.A.R., and Bostad L. Observation should be considered as an alternative in management of renal masses in old and comorbid patients!. Eur Urol 55 (2009) 1419-1429
2. Van Poppel H., and Joniau S. Is surveillance an option for the treatment of small renal masses?. Eur Urol 52 (2007) 1323-1330
3. Ozsoy M., Klatte T., Waldert M., and Remzi M. Surveillance for the management of small renal masses. Adv Urol (2008) article 196701
4. Chawla S.N., Crispen P.L., Hanlon A.L., Greenberg R.E., Chen D.Y., and Uzzo R.G. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006) 425-431
5. Becker F., Suttmann H., Siemer S., and Stöckle M. Is there a place for surveillance in the management of small renal tumors?. Nat Clin Pract Urol 3 (2006) 626-627
6. Volpe A., and Jewett M.A. The role of surveillance for small renal masses. Nat Clin Pract Urol 4 (2007) 2-3
7. Remzi M., and Marberger M. Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how?. Eur Urol 55 (2009) 359-367
8. Romis L., Cindolo L., Patard J.J., et al. Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 45 (2004) 53-57
9. Aslam M.I., Spencer L., Garcea G., et al. A case of liver metastasis from an oncocytoma with a focal area of chromophobe renal cell carcinoma: a wolf in sheep's clothing. Int J Surg Pathol 17 (2009) 158-162
10. Davis C.J., Sesterhenn I.A., and Mostofi F.K. Renal oncocytoma: clinicopathological study of 166 patients. J Urogenital Pathol 1 (1991) 41-52
11. Klatte T., Han K.R., Said J.W., et al. Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol Oncol 26 (2008) 604-609
12. Licht M.R., Novick A.C., Tubbs R.R., Klein E.A., Levin H.S., and Streem S.B. Renal oncocytoma: clinical and biological correlates. J Urol 150 (1993) 1380-1383
13. Neuzillet Y., Lechevallier E., Andre M., Daniel L., Nahon O., and Coulange C. Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urology 66 (2005) 1181-1185
14. Liu L., Qian J., Singh H., Meiers I., Zhou X., and Bostwick D.G. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 131 (2007) 1290-1297
15. Stoerkl S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma: workgroup no. 1. Union International contre le cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 (1997) 987-989
16. Hollingsworth J.M., Miller D.C., Daignault S., and Hollenbeck B.K. Rising incidence of small renal masses: a need to reassess treatment effect. J Nat Cancer Inst 98 (2006) 1331-1334
17. Schmidbauer J., Remzi M., Memarsadeghi M., et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol 53 (2008) 1003-1012
18. Neuzillet Y., Lechevallier E., Andre M., Daniel L., and Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol 171 (2004) 1802-1805
19. Lechevallier E., André M., Barriol D., et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216 (2000) 506-510
20. Cindolo L., de la Taille A., Schips L., et al. Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database. Urology 65 (2005) 681-686
21. Patard J.J., Leray E., Rioux-Leclercq N., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23 (2005) 2763-2771
22. Mai K.T., Dhamanaskar P., Belanger E., and Stinson W.A. Hybrid chromophobe renal cell neoplasm. Pathol Res Pract 201 (2005) 385-389
23. Dechet C.B., Bostwick D.G., Blute M.L., Bryant S.C., and Zincke H. Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urol 162 (1999) 40-42
24. Remzi M., Katzenbeisser D., Waldert M., et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int 99 (2007) 1002-1006